BR1019
/ Boryung Group
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
December 13, 2024
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=52 | Completed | Sponsor: Boryung Pharmaceutical Co., Ltd | Active, not recruiting ➔ Completed
Trial completion • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
November 08, 2024
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=52 | Active, not recruiting | Sponsor: Boryung Pharmaceutical Co., Ltd | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
October 15, 2024
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=52 | Not yet recruiting | Sponsor: Boryung Pharmaceutical Co., Ltd
New P1 trial • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
April 02, 2024
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"
(clinicaltrials.gov)
- P1 | N=52 | Completed | Sponsor: Boryung Pharmaceutical Co., Ltd | Recruiting ➔ Completed
Trial completion • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
January 26, 2024
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"
(clinicaltrials.gov)
- P1 | N=52 | Recruiting | Sponsor: Boryung Pharmaceutical Co., Ltd
New P1 trial • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 5
Of
5
Go to page
1